Planta Medica · 2004 · 25 citations · 0 references
MedicineMedicinal ChemistryPharmacologyBone MetabolismMineral MetabolismPharmacodynamicsBone Density RegulationBone HealthBone MineralizationBone PhysiologyBone QualityMetabolic Bone DiseaseBone Matrix Mineral ContentBone Mineral DensityBone Mineral LossBone StrengthBone Strength AssessmentDrug Effects On Bone DensityExtractPostmenopausal Bone Resorption
The antiosteoporotic activity of the 90 % EtOH fraction of the water extract of rhizomes of Dioscorea spongiosa and methylprotodioscin, its major constituent, were examined in the model of postmenopausal bone loss using ovariectomized (OVX) rats or mice. After 6 weeks treatment, the proximal tibia of rats or mice and the distal femora of mice were scanned by peripheral quantitative computed tomography (pQCT). Both the 90 % EtOH fraction (100 mg/kg/d) and methylprotodioscin (50 mg/kg/d) significantly inhibited bone loss in bone mineral content (BMC) and bone mineral density (BMD) in total, cancellous and cortical bones, and the decrease in bone strength indexes induced by OVX, without side effect on the uterus.